“Oleandrin and its derivative Odoroside A, both cardiac glycosides, exhibit anticancer effects by inhibiting invasion via suppressing the STAT-3 signaling pathway”.
Intnl. J. Mol. Sci. 2018, 19(11); 3350. Ko YS, Rugira T, Jin H, Park SW and Kim HJ. This article demonstrates that oleandrin and odoroside A, both of which are contained within PBI-05204, are effective at inhibiting the invasive capacity of human breast cancer cells. In addition, they reduce breast cancer stem cell activity. READ ARTICLE